Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 18/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL975404 | 1.00 | ALOX5AP (0.44) | ALOX5APPDE10AGABRA1GABRG2GABRB3 | |
| SCHEMBL975428 | 0.90 | ALOX5AP (0.45) | ALOX5APGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL975429 | 0.90 | ALOX5AP (0.45) | ALOX5APGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL12920617 | 0.84 | ALOX5AP (0.54) | ALOX5APALOX5 | |
| SCHEMBL976419 | 0.84 | ALOX5AP (0.54) | ALOX5APALOX5 | |
| SCHEMBL976095 | 0.84 | ALOX5AP (0.50) | ALOX5AP | |
| SCHEMBL976094 | 0.84 | ALOX5AP (0.50) | ALOX5AP | |
| SCHEMBL12948098 | 0.83 | ALOX5AP (0.52) | ALOX5APALOX5 | |
| SCHEMBL976624 | 0.81 | ALOX5AP (0.48) | ALOX5APALOX5 | |
| SCHEMBL976622 | 0.81 | ALOX5AP (0.48) | ALOX5APALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110003815-A1 | DIPHENYL SUBSTITUTED CYCLOALKANES | MERCK & CO., INC. | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003815-A1 | DIPHENYL SUBSTITUTED CYCLOALKANES | PTGIS, PTGS1, LTC4S | ALOX5AP 47/4885PDE10A 1523/4885GABRA1 2918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.